Squarepoint
BNTX icon

Squarepoint’s BioNTech BNTX Stock Holding History

Squarepoint’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.7M Buy
298,200
+271,000
+996% +$25.5M 0.03% 553
2026
Q1 		$2.42M Buy
27,200
+15,600
+134% +$1.6M ﹤0.01% 2045
2025
Q4 		$1.1M Buy
11,600
+5,600
+93% +$564K ﹤0.01% 2517
2025
Q3 		$592K Buy
+6,000
New +$642K ﹤0.01% 3111
2025
Q2 		– Sell
-3,700
Closed -$337K – 4508
2025
Q1 		$337K Sell
3,700
-82,100
-96% -$9.19M ﹤0.01% 3652
2024
Q4 		$9.78M Buy
85,800
+23,800
+38% +$2.72M 0.01% 1173
2024
Q3 		$7.36M Buy
+62,000
New +$5.7M 0.01% 1158
2024
Q2 		– Sell
-36,800
Closed -$3.39M – 4075
2024
Q1 		$3.39M Buy
36,800
+22,800
+163% +$2.19M 0.01% 1736
2023
Q4 		$1.48M Sell
14,000
-10,900
-44% -$1.1M ﹤0.01% 2229
2023
Q3 		$2.71M Sell
24,900
-48,500
-66% -$5.36M 0.01% 1582
2023
Q2 		$7.92M Buy
73,400
+55,600
+312% +$6.25M 0.02% 794
2023
Q1 		$2.22M Buy
17,800
+7,800
+78% +$1.07M 0.01% 1361
2022
Q4 		$1.5M Buy
+10,000
New +$1.54M 0.01% 1541
2022
Q2 		– Sell
-8,000
Closed -$1.36M – 2899
2022
Q1 		$1.36M Buy
+8,000
New +$1.34M 0.01% 1396

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Squarepoint's BNTX Position: Q2 2026 in Review

Squarepoint increased its BioNTech (BNTX) stake by 140% in Q2 2026, buying an estimated $10.9M and bringing the position to 199,004 shares worth $18.5M. The position accounts for 0.02% of the portfolio, ranked #733.

Squarepoint first reported a position in BNTX in Q2 2020 and has held it in 23 quarters since. The position peaked at $42.1M in Q4 2024. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Squarepoint held 199,004 shares of BioNTech worth $18.5M as of Q2 2026.
  • Squarepoint bought 116,155 BioNTech shares in Q2 2026, an estimated $10.9M.
  • BioNTech made up 0.02% of Squarepoint's portfolio in Q2 2026, its #733 holding.
  • Squarepoint first reported a position in BioNTech in Q2 2020 and has held it in 23 quarters since.
  • Squarepoint's BioNTech position peaked at $42.1M in Q4 2024.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.